fda warning letters glp-1 compounders september 2025 Issues 30 to Telehealth Firms Over Misleading Compounded Marketing CDER Warning Letters Jump 50%

In a sensitivity analysis restricted to placebo-controlled ALC monotherapy trials (4 studies), the pooled estimate also favored ALC (SMD 2.41, 95% CI 4.43 to 0.39

doi: 10.1055/s-0042-109065 Summary Keywords diabetes mellitus type 2, cardiovascular disease, cardiovascular risk, diabetic kidney disease, sodium-glucose cotransporter-2 inhibitor, glucagon-like peptide-1 receptor agonist, aldosterone, renin Citation Puglisi S, Rossini A, Poli R, Dughera F, Pia A, Terzolo M and Reimondo G (2021) Effects of SGLT2 Inhibitors and GLP-1 Receptor Agonists on Renin-Angiotensin-Aldosterone System

Those who took L-carnitine did much better than those who took the medication, particularly after receiving the supplement for 4 to 8 weeks

Gimnez-Palomo A, Dodd S, Anmella G, et al

Black Coffee or Unsweetened Tea: This is generally considered acceptable

The REWIND trial (Researching Cardiovascular Events with a Weekly Incretin in Diabetes) provided important cardiovascular outcome data